Regulation of CYP24 splicing by 1,25-dihydroxyvitamin D₃ in human colon cancer cells

Document Type

Article

Abstract

CYP24 is a well-established vitamin D receptor (VDR) target gene. The active VDR ligand 1,25(OH)₂D₃ regulates its own catabolism by increasing CYP24 expression. It is well known that in the presence of 1,25(OH)₂D₃, VDR binds to VDREs in the promoter region of CYP24 and initiates CYP24 transcription. However, little is known about the role of 1,25(OH)₂D₃ in the posttranscriptional modulation of CYP24. In this study, we investigated the functional significance of 1,25(OH)₂D₃ in CYP24 RNA splicing in colon cancer cells. Using RT-PCR, we found that 1,25(OH)₂D₃ actively induces CYP24 splicing in a time-dependent manner and CYP24 splicing pattern could be cell type or tissue specific. The induction of RNA splicing by 1,25(OH)₂D₃ was mainly CYP24 selective. Treatment of cells with parathyroid hormone inhibited basal CYP24 splicing, but failed to inhibit 1,25(OH)₂D₃-induced CYP24 splicing. Further experiments demonstrated that new RNA synthesis was required for the induction of CYP24 splicing by vitamin D. In addition, alteration of multiple signaling pathways also affected CYP24 splicing and cellular sensitivity in response to vitamin D appeared to correlate with the induction of CYP24 splicing. These results suggest that 1,25(OH)₂D₃ not only regulates CYP24 transcription, but also plays an important role in posttranscriptional modulation of CYP24 by inducing its splicing. Our findings reveal an additional regulatory step that makes the vitamin D mediated action more prompt and efficient.

Medical Subject Headings

Aberrant Crypt Foci (metabolism, pathology); Biopsy; Calcitriol (metabolism); Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic (metabolism); Colon (metabolism, pathology); Colonic Neoplasms (metabolism, pathology); Humans; Molecular Weight; Neoplasm Proteins (genetics, metabolism); Osmolar Concentration; Parathyroid Hormone (analogs & derivatives, metabolism); Protein Kinase Inhibitors (pharmacology); RNA Splicing (drug effects); RNA, Messenger (chemistry, metabolism); Real-Time Polymerase Chain Reaction; Reproducibility of Results; Signal Transduction (drug effects); Steroid Hydroxylases (chemistry, genetics, metabolism); Vitamin D3 24-Hydroxylase

Publication Date

2-1-2012

Publication Title

The Journal of endocrinology

E-ISSN

1479-6805

Volume

212

Issue

2

First Page

207

Last Page

15

PubMed ID

22068926

Digital Object Identifier (DOI)

10.1530/JOE-11-0305

Link to Full Text

Share

COinS